文献速递肿瘤 PET/CT

FDG PET/CT用于肺癌分期:进展更新

FDG PET/CT for Staging Lung Carcinoma: An Update.
PubMed 文献 · Semin Nucl Med · 2025-02-28

本文综述FDG PET/CT在非小细胞肺癌(NSCLC)和小细胞肺癌(SCLC)分期中的作用。在NSCLC中,CT部分对T分期至关重要,FDG部分可提供N分期附加信息,FDG PET/CT识别淋巴结受累的总体灵敏度85%、特异度84%,并汇总了预测FDG PET/CT漏诊淋巴结受累的参数及已发表的列线图。在SCLC中,有限数据显示FDG PET/CT分期较常规分期更准确,可使最多15%的患者疾病分期发生改变。

要点

  • NSCLC中FDG PET/CT识别淋巴结受累的总体灵敏度85%、特异度84%。
  • 肿瘤大小及随时间增大、分化程度、确诊至检查天数、腺癌亚型、中央型位置、实性成分等参数可能预测FDG PET/CT漏诊的淋巴结受累。
  • SCLC中FDG PET/CT分期较常规分期更准确,最多15%患者分期改变(局限期与广泛期之间)。

核心结论

  • 在NSCLC中,FDG PET/CT的CT部分对T分期评估至关重要,FDG部分可提供N分期的附加信息。
  • FDG PET/CT识别NSCLC淋巴结受累的总体灵敏度85%、特异度84%。
  • FDG PET/CT识别胸外转移的总体灵敏度高于常规形态学影像,尤其对骨和肾上腺病灶。
  • 在SCLC中,有限数据表明FDG PET/CT分期较常规分期更准确,最多15%的患者疾病分期发生改变(局限期与广泛期之间)。

研究设计与样本

  • 综述,检索范围及纳入文献数量原文未报告。

主要发现

  • NSCLC中FDG PET/CT识别淋巴结受累的总体灵敏度85%、特异度84%。
  • 可能预测FDG PET/CT漏诊淋巴结受累的参数包括肿瘤大小及其随时间增大、肿瘤分化程度、自初诊起经过的天数、腺癌亚型、原发肿瘤中央型与周围型位置、实性与混合性实性-磨玻璃的影像学特征。
  • 已发表纳入上述部分变量的列线图并可供临床使用。
  • FDG PET/CT识别胸外转移的总体灵敏度高于常规形态学影像,尤其对骨和肾上腺病灶。
  • SCLC中有限数据显示FDG PET/CT分期较常规分期更准确,最多15%患者分期改变(局限期与广泛期之间)。

关键数值与推荐

  • NSCLC中FDG PET/CT识别淋巴结受累的总体灵敏度85%、特异度84%。
  • SCLC中FDG PET/CT使最多15%的患者疾病分期发生改变(局限期与广泛期之间)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • SCLC中可用的数据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In non-small cell lung carcinoma (NSCLC) carcinoma, the CT-part of the FDG PET/CT examination is of primary importance for T (tumor)-status assessment, while information derived from the primary tumor on the FDG-part of the examination may provide additional information on N- (lymph node) status. FDG PET/CT imaging was shown to have an overall sensitivity of 85% and a specificity of 84% for identifying LN involvement in NSCLC. Parameters that may predict the presence and quantify the risk of LN-involvement in NSCLC missed on FDG PET/CT imaging are tumor size and its increase over time, tumor differentiation degree, the number of days elapsed from the time of initial diagnosis, an adenocarcinoma subtype, a central versus peripheral location of the primary tumor and a solid versus mixed solid-ground glass radiologic character. Nomograms incorporating several of these variables have been published and made available for clinical usage. Furthermore, FDG PET/CT imaging was shown to have an overall higher sensitivity for identifying extra-thoracic metastases than convential morphological imaging and this especially for bone and adrenal lesions. In small cell lung carcinoma (SCLC), limited available data have shown FDG PET/CT imaging to be systematically more accurate for staging purposes when compared to conventional staging and to lead to a change in disease stage (limited versus extensive disease) in up to 15% of SCLC-patients.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Sathekge C, Maes J, Maes A, et al. FDG PET/CT for Staging Lung Carcinoma: An Update. Semin Nucl Med. 2025. PMID: 40023683. doi:10.1053/j.semnuclmed.2025.01.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。